CATHERINE HODSDON: Open Payments
NPI 1992356307 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,493 in 63 payments from 11 companies in 2025. Trend: 2023 $1,034 · 2024 $1,206 · 2025 $1,493
Food & beverage: $1,391Education: $101
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 22 | $562 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $180 |
| Alkermes, Inc. | 3 | $166 |
| Teva Pharmaceuticals USA, Inc. | 6 | $161 |
| Otsuka America Pharmaceutical, Inc. | 6 | $104 |
| ABBVIE INC. | 5 | $82 |
| Braeburn Inc. | 4 | $78 |
| Indivior Inc. | 4 | $69 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| Luye Pharma (USA) Ltd. | 1 | $21 |
Products named: HETLIOZ, FANAPT, CAPLYTA, LYBALVI, VRAYLAR, BRIXADI, SUBLOCADE, ABILIFY ASIMTUFII.
Industry payments across NC — which companies pay providers there.
